CAS 102971-73-3

Butanoic acid,4-[[2-carboxy-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]thio]-,1-(1,1-dimethylethyl) ester, (R)-

Description:

Butanoic acid, 4-[[2-carboxy-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]thio]-, 1-(1,1-dimethylethyl) ester, (R)-, is a complex organic compound characterized by its functional groups and stereochemistry. It features a butanoic acid backbone, which contributes to its acidic properties, and includes a thioether linkage due to the presence of a sulfur atom in its structure. The molecule also contains a fluorenylmethoxycarbonyl (Fmoc) protecting group, commonly used in peptide synthesis to protect amino groups. The (R)- designation indicates that the compound has a specific chiral configuration, which can influence its biological activity and interactions. This compound is likely to be soluble in organic solvents and may exhibit moderate solubility in water due to the presence of polar functional groups. Its structure suggests potential applications in medicinal chemistry, particularly in the development of peptide-based therapeutics. Overall, the compound's unique characteristics stem from its intricate arrangement of functional groups and stereochemistry, making it a subject of interest in chemical research and synthesis.

Formula: C₂₆H₃₁NO₆S

Synonyms:

• Fmoc-L-Cys(PrCO-OtBu)-OH

(R)-Fmoc-2-amino-3-(3-tert-butoxycarbonyl-propylsulfanyl)-propionic acid

CAS: 102971-73-3

Formula: C₂₆H₃₁NO₆S

Purity: 97%

Color and Shape: Solid

Molecular weight: 485.5924

Ref: IN-DA008WZW

N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-S-(4-(tert-butoxy)-4-oxobutyl)-L-cysteine

CAS: 102971-73-3

N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-S-(4-(tert-butoxy)-4-oxobutyl)-L-cysteine

Purity: 97%

Ref: 54-OR1037985

N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-S-(4-(tert-butoxy)-4-oxobutyl)-L-cysteine

CAS: 102971-73-3

Purity: 97%

Molecular weight: 485.6000061

Ref: 10-F616746

Fmoc-Cys(3-(t-butoxycarbonyl)-propyl)-OH

CAS: 102971-73-3

Fmoc-Cys(3-(t-butoxycarbonyl)-propyl)-OH is a cysteine derivative that has been shown to be effective in the treatment of ulcers. It is a competitive inhibitor of the enzyme cyclooxygenase, which is responsible for the production of prostaglandins, and can be used to decrease inflammation. Fmoc-Cys(3-(t-butoxycarbonyl)-propyl)-OH has been shown to inhibit carassius erythrocyte meiosis, with an effective dose of 0.02 mM. The drug also has a conformation that can bind to the hydroxamic acid moiety, which is thought to be responsible for its anti-inflammatory properties. This drug also inhibits genotype 3a2 and 5b2 of Cyprinus carpio and may have potential as a chemotherapeutic agent for these genotypes.END>

Formula: C₂₆H₃₁NO₆S

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 485.59 g/mol

Ref: 3D-FF157403